Clinical Trials Directory

Trials / Completed

CompletedNCT02891356

Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years

Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years and Relationship Between Bone Loss and Adipokines.

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The mechanism of bone loss in anorexia nervosa is complex. Marrow adipose tissue seems to play a role in the regulation of bone metabolism. Adipocytes secrete cytokines and adipokines that either stimulate or inhibit adjacent osteoblasts. This study consist to explore the relationship in anorexia nervosa patients with change in bone mineral density and adipokines like leptin, adiponectin and Préf-1 Bone mineral densities will be measure in 180 anorexia nervosa patients at inclusion and every two years during 6 years.It is assessed blood and urinary calcium and phosphate levels, bone remodelling markers and adipokines (leptin, adiponectin and Préf-1)

Conditions

Interventions

TypeNameDescription
DEVICEDEXAThe Dual Energy X-ray Absorptiometry (DEXA) is a third generation multi-captor DEXA device that allow short duration measurements. It measures Bone Mineral Density (BMD) at the spine and the femoral neck

Timeline

Start date
2013-07-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2016-09-07
Last updated
2025-12-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02891356. Inclusion in this directory is not an endorsement.